Skip to main content
SpringerLink
Log in

Akute Leukämien

  • Chapter
Therapie innerer Krankheiten

  • 18 Accesses

Zusammenfassung

Akute Leukämien sind maligne Erkrankungen hämatopoetischer Stammzellen, die bei erhaltener Teilungsfähigkeit mit einem teilweisen oder völligem Verlust der Fähigkeit zur Ausdifferenzierung zu reifen Funktionszellen verbunden sind. Je nach betroffener hämatopoetischer Zellreihe wird zwischen den beiden Hauptformen der akuten lymphatischen und der akuten myeloischen Leukämie unterschieden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bennett JM, Catovsky D, Daniel MT et al. (1985) Proposed revised criteria of the classification of acute myeloid leukemia. Ann Intern Med 103: 626–629

    Article  Google Scholar 

  2. Bishop JF, Matthews JP, Graham AY et al. (1996) A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 87: 1710–1717

    CAS  PubMed  Google Scholar 

  3. Büchner T (1996) Akute myeloische Leukämie. Internist 37: 1008–1012

    PubMed  Google Scholar 

  4. Büchner T, Hiddemann W, Wörmann B et al. (1998) Intensified therapy of AML–the role of the HAM combination. In: Hiddemann W, Büchner T, Wörmann B, Ritter J, Creutzig U, Keating M, Plunkett W (eds) Acute Leukemias VII: Experimental Approaches and Novel Therapies: Springer-Verlag 821–824

    Chapter  Google Scholar 

  5. Büchner T, Hiddemann W, Koenigsmann M et al. (1991) Recombinant human granulocyte-macrophage colony-stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age or after relapse. Blood 78: 1190–1197

    PubMed  Google Scholar 

  6. Büchner T, Urbanitz D, Hiddemann W et al. (1985) Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): Two multicenter studies of the German AML Cooperative Group. J Clin Oncol 3: 1583–1589

    PubMed  Google Scholar 

  7. Camitta B. Mahoney D, Leventhal B et al. (1994) Intensive intravenous methotrexate and mercaptopurine treatment of higher risk non-T, non-B acute lymphocytic leukemia. A Pedriatric Oncology Group Study. J Clin Oncol 12: 1383–1389

    CAS  PubMed  Google Scholar 

  8. Cassileth PA, Lynch E, Hines JD et al. (1992) Varying intensity of postremission therapy in acute myeloid leukemia. Blood 79: 1924–1930

    CAS  PubMed  Google Scholar 

  9. Cheson BD, Cassileth PA, Head DR et al. (1990) Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and responses on acute myeloid leukemia. J Clin Oncol 8: 813–819

    CAS  PubMed  Google Scholar 

  10. Clarkson B, Gaynor J, Little C et al. (1990) Importance of long-term follow-up in evaluating treatment regimens for adults with acute lymphoblastic leukemia. Hematol Blood Transfus 33: 397–408

    CAS  Google Scholar 

  11. Cline MJ (1994) The molecular basis of leukemia. N Engl J Med 330: 328–336

    Article  CAS  PubMed  Google Scholar 

  12. Degos L (1994) Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival. Leukemia 8: 9111–9113

    Google Scholar 

  13. Dekker AW, van’t Veer MB, Haak HL et al. (1994) Conventional remisson induction followed by intensive consolidation without maintenance therapy in adult acute lymphoblastic leukemia. Results from a phase II clinical trial in 130 patients. Blood 84, Suppl 1: 144a

    Google Scholar 

  14. Dicke KA, Hoelzer D, Gorin NC et al. (1993) The role of bone marrow transplantation in adult acute lymphocytic leukemia. Ann Oncol 4: 581–590

    Article  Google Scholar 

  15. European Group for the Immunological Characterization of Leukemias (EGIL); Bene MC, Castoldi G, Knapp W et al. (1995) Proposals for the immunological classification of acute leukemias. Leukemia 9:1783–1786

    Google Scholar 

  16. Fiere D, Lepage E, Sebban C et al. (1993) Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. J Clin Oncol 11: 1990–2001

    CAS  PubMed  Google Scholar 

  17. Gale RP, Büchner T Horowitz MM, Zhang MJ (1993) Chemotherapy versus bone marrow transplantation for adults with acute myelogenous leukemia (AML) in first remission. Blood 82; Suppl:168 a

    Google Scholar 

  18. Hoelzer D (1993) Acute lymphoblastic leukemia–progress in children, less in adults. N Engl J Med 329: 1343–1345

    Article  CAS  PubMed  Google Scholar 

  19. Hoelzer D (1994) Treatment of acute lymphoblastic leukemia. Sem Hemtol 31: 1–15

    CAS  Google Scholar 

  20. Hoelzer D, Ludwig WD, Thiel E et al. (1996) Improved outcome in adult-B-cell acute lymphoblastic leukemia. Blood 87: 495–452

    CAS  PubMed  Google Scholar 

  21. Larson RA, Dodge RK, Burns CP et al. (1995) A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood 5: 2025–2037

    Google Scholar 

  22. Mandelli F, Annino L, Vegna ML et al. (1996) Adult acute lymphoblastic leukemia (ALL): Results of the Gimema ALL 0288 trial. Br J Hematol 93: 144–152

    Google Scholar 

  23. Mayer RJ, Davis RB, Schiffer CA et al. (1994) Intensive post-remission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331: 896–942

    Article  CAS  PubMed  Google Scholar 

  24. Ohno R, Tomonaga M, Kobayashi T et al. (1990) Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. N Engl J Med 323: 871–877

    Article  CAS  PubMed  Google Scholar 

  25. Ottmann OG, Hoelzer D, Gracien E et al. (1995) Concomittant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomised phase II trial. Blood 86: 444–454

    CAS  PubMed  Google Scholar 

  26. Rowe JM, Andersen J, Mazza JJ et al. (1993) Phase III randomized placebo-controlled study of granulocyte-macrophage-colony stimulating factor (GM-CSF) in adult patients (55–7o years) with acute myelogenous leukemia (AML). A study of the Eastern Cooperative Oncology Group (ECOG). Blood 82; Suppl 1:329 a

    Google Scholar 

  27. Swansbury GJ, Lawler SD, Alimena G et al. (1994) Longterm survival in acute myelogenous leukemia: A second follow-up of the Fourth International Workshop on chromosomes in leukemia. Cancer Genet Cytogenet 73: 1–7

    Article  CAS  PubMed  Google Scholar 

  28. von Schilling C, Duyster J, Herrmann F (1996) Fortschritte im Verständnis der Leukämieentstehung. Internist 37: 971–981

    Google Scholar 

  29. Warrell RP, Frankel SR, Miller WH et al. (1991) Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324: 1385–1393

    Article  PubMed  Google Scholar 

  30. Zittoun RA, Mandelli F,Willemze R et al. (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 332: 217–223

    Article  CAS  PubMed  Google Scholar 

Download references

Authors
  1. W. Hiddemann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik und Poliklinik II Klinikum Großhadern, Ludwig-Maximilians-Universität München, Marchioninistraße 15, D-81377, München, Deutschland

    Gustav Paumgartner

  2. Neurologische Klinik und Poliklinik, Universität München Klinikum Großhadern, Marchioninistraße 15, D-81377, München, Deutschland

    Th. Brandt

  3. Medizinische Kernklinik und Poliklinik, Universitäts-Krankenhaus Eppendorf, Martinistraße 52, D-20246, Hamburg, Deutschland

    H. Greten

  4. Abteilung für Nephrologie Zentrum Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, Carl-Neuberg-Straße 1, D-30625, Hannover, Deutschland

    K. M. Koch

  5. Krankenhaus Zehlendorf Pneumologie I, Am Heckeshorn 33, D-14109, Berlin, Deutschland

    H. Lode

  6. Medizinische Universitätsklinik, Innere Medizin A, Albert-Schweitzer-Straße 33, D-48149, Münster, Deutschland

    J. van de Loo

  7. Medizinische Poliklinik, Universität München, Pettenkoferstraße 8a, D-80336, München, Deutschland

    M. Schattenkirchner

  8. Medizinische Klinik II, Universität Gießen, Klinikstraße 36, D-35392, Gießen, Deutschland

    W. Seeger

  9. Medizinische Klinik und Poliklinik I Klinikum Großhadern, Ludwig-Maximilians-Universität München, Marchioninistraße 15, D-81377, München, Deutschland

    G. Steinbeck

  10. Medizinische Klinik und Poliklinik, Universität Heidelberg, Bergheimer Straße 58, D-69115, Heidelberg, Deutschland

    R. Ziegler

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hiddemann, W. (1999). Akute Leukämien. In: Paumgartner, G., et al. Therapie innerer Krankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10477-4_62

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-10477-4_62

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-10478-1

  • Online ISBN: 978-3-662-10477-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation